EUVIMEDEUVIMED entdecken
Open Access

Loss of function in protein Z (PROZ) is associated with increased risk of ischemic stroke in the UK Biobank

Amelia K Haj, Justine Ryu, Sean J Jurgens, Sharjeel Chaudhry, Satoshi Koyama, Xin Wang, Seung Hoan Choi, Cody Hou, Simone Sanna-Cherchi, Christopher D Anderson, Patrick T Ellinor, Pavan K Bendapudi

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2024.09.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Amelia K Haj und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA; Cardiovascular Disease Initiative, The Broad Institute of MIT an…. Hauptthemen laut MEDLINE: Ischemic Stroke, Loss of Function Mutation, Blood Coagulation Factors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, European Commission, National Heart Lung and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The vitamin K-dependent coagulation factor protein Z (PZ), encoded by the PROZ gene, is canonically considered to have anticoagulant effects through negative regulation of factor Xa. Paradoxically, higher circulating PZ concentrations have repeatedly been associated with an elevated risk of acute ischemic stroke. OBJECTIVES: We performed a large-scale genetic association study to examine the relationship between germline genetic variants in PROZ and the risk of ischemic stroke. METHODS: Using whole-exome sequencing and clinical data for 416 711 participants in the UK Biobank (UKB), we identified individuals with rare (minor allele frequency ≤0.1%) putatively function-altering variants in PROZ. Using Firth's logistic regression and controlling for known stroke risk factors, we evaluated the association between variant carrier status and noncardioembolic ischemic stroke (NCEIS). Additionally, we evaluated differences in the plasma levels of 1472 proteins between PROZ variant carriers and noncarriers in a subset of 48 893 UKB participants. RESULTS: After accounting for missing data, qualifying variants in PROZ were identified in 414 UKB participants (99.0% heterozygous). Variant carriers had a significantly increased risk of NCEIS (odds ratio, 2.34; 95% CI, 1.15-4.13; P = .02) but not of venous thromboembolism, myocardial infarction, or peripheral artery disease. Plasma proteomics analysis revealed that PROZ variant carriers had significantly elevated levels of 2 proteins related to the response to cerebral ischemia, peroxiredoxins 1 and 6 (PRDX1: fold change, 1.83; P = 1.3 × 10-5; PRDX6: fold change, 1.78; P = 9.6 × 10-10). CONCLUSION: Lifelong exposure to decreased PZ levels confers a significantly increased risk of NCEIS, consistent with the role of PZ as an anticoagulant factor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeLoss of Function MutationBlood Coagulation FactorsHumansMaleFemaleUnited KingdomMiddle AgedBiological Specimen BanksRisk FactorsAgedGenetic Predisposition to DiseaseRisk AssessmentExome SequencingPhenotypeGene FrequencyGenetic Association StudiesHeterozygoteUK BiobankBlood Proteins

Stichwörter der Autor:innen

genomicsischemic strokeproteomicsthrombosis

Substanzen

plasma protein ZBlood Coagulation FactorsBlood Proteins

Autor:innen und Institutionen

  • Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA; Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Harvard Medical School, Bost…
  • Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Section of Hematology, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Experimental Cardi…
  • Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA; Division of Hemostasis and Thrombosis, Beth Israel Deaconess…
  • Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Cardiovascular Disease Initiative, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.

Förderung

  • NHLBI NIH HHS
  • European Commission
  • National Heart Lung and Blood Institute
  • National Institutes of Health
  • Hartstichting
  • American Heart Association

Zitieren

APA

Haj, A. K., Ryu, J., Jurgens, S. J., Chaudhry, S., Koyama, S., Wang, X., Choi, S. H., Hou, C., Sanna-Cherchi, S., Anderson, C. D., Ellinor, P. T., & Bendapudi, P. K. (2025). Loss of function in protein Z (PROZ) is associated with increased risk of ischemic stroke in the UK Biobank. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.09.016

Vancouver

Haj AK, Ryu J, Jurgens SJ, Chaudhry S, Koyama S, Wang X, et al. Loss of function in protein Z (PROZ) is associated with increased risk of ischemic stroke in the UK Biobank. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2024.09.016

BibTeX
@article{Haj2025,
  author = {Haj, Amelia K and Ryu, Justine and Jurgens, Sean J and Chaudhry, Sharjeel and Koyama, Satoshi and Wang, Xin and Choi, Seung Hoan and Hou, Cody and Sanna-Cherchi, Simone and Anderson, Christopher D and Ellinor, Patrick T and Bendapudi, Pavan K},
  title = {Loss of function in protein Z (PROZ) is associated with increased risk of ischemic stroke in the UK Biobank},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2024.09.016}
}
Kostenlos starten →